MedTrace Logo

Conversational AI in Tactical Casualty Care: Baseline GPT-4o Improves Combat Medic Decision-Making

NCT06796036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-05-13

No results posted yet for this study

Summary

The aim of the project is to investigate whether the integration of artificial intelligence (AI) support, specifically through the GPT-4 model, enhances the decision-making processes of military medical first responders within the framework of Tactical Combat Casualty Care (TCCC). The study focuses on AI's ability to assist in ventilator settings for injured individuals in combat scenarios, emphasizing improved accuracy and decision-making speed. The project tests the hypothesis that the use of AI can positively impact outcomes without compromising the autonomy of first responders. The results have the potential to optimize patient care in challenging conditions and contribute to the advancement of combat medicine.

Conditions

  • Artificial Intelligence

Interventions

OTHER

Combat Medic Decision-Making with and without artificial intelligence assistance

Participants will complete 10 simulated Tactical Combat Casualty Care (TCCC) scenarios, with 5 scenarios conducted using AI assistance (GPT-4) and 5 without AI. In AI-assisted scenarios, participants will use GPT-4 to query and optimize ventilator settings based on patient data, while non-AI scenarios rely solely on their clinical judgment.

Sponsors & Collaborators

  • Czech Technical University in Prague

    collaborator OTHER

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Michal Soták, M.D., Ph.D. · Charles University, Czech Republic

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-02
Primary Completion
2025-03-31
Completion
2025-04-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06796036 on ClinicalTrials.gov